These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6208336

  • 1. Serotonin receptor changes in dementia of the Alzheimer type.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JA.
    J Neurochem; 1984 Dec; 43(6):1574-81. PubMed ID: 6208336
    [Abstract] [Full Text] [Related]

  • 2. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
    Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R.
    Neuropharmacology; 1984 Dec; 23(12B):1561-9. PubMed ID: 6084823
    [Abstract] [Full Text] [Related]

  • 3. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL, Engisch KL.
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [Abstract] [Full Text] [Related]

  • 4. The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA.
    Neurobiol Aging; 1986 Sep; 7(1):3-7. PubMed ID: 2869422
    [Abstract] [Full Text] [Related]

  • 5. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.
    Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE.
    J Neurol Sci; 1984 May; 64(2):109-17. PubMed ID: 6747659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
    Bowen DM, Procter AW, Mann DM, Snowden JS, Esiri MM, Neary D, Francis PT.
    Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus.
    Dewar D, Graham DI, McCulloch J.
    J Neural Transm Park Dis Dement Sect; 1990 Mar; 2(2):129-37. PubMed ID: 2222780
    [Abstract] [Full Text] [Related]

  • 12. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
    Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE.
    Neurosci Lett; 1984 Oct 26; 51(3):353-7. PubMed ID: 6521962
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H, Moroji T, Kosaka K.
    Neurosci Lett; 1984 Nov 23; 52(1-2):73-8. PubMed ID: 6152043
    [Abstract] [Full Text] [Related]

  • 14. Striatal dopamine receptors in Alzheimer-type dementia.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Markakis D.
    Neurosci Lett; 1984 Nov 23; 52(1-2):1-6. PubMed ID: 6241300
    [Abstract] [Full Text] [Related]

  • 15. Characterization and localization of serotonin receptors in human brain postmortem.
    Biegon A, Kargman S, Snyder L, McEwen BS.
    Brain Res; 1986 Jan 15; 363(1):91-8. PubMed ID: 2936426
    [Abstract] [Full Text] [Related]

  • 16. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1980 Dec 15; 20(3):373-7. PubMed ID: 6108540
    [Abstract] [Full Text] [Related]

  • 17. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM, Janssen PF, Leysen JE.
    Eur J Pharmacol; 1982 Jun 16; 81(1):43-8. PubMed ID: 7117369
    [Abstract] [Full Text] [Related]

  • 18. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
    Koshimura K, Kato T, Tohyama I, Nakamura S, Kameyama M.
    J Neurol Sci; 1986 Dec 16; 76(2-3):143-50. PubMed ID: 3794747
    [Abstract] [Full Text] [Related]

  • 19. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM, Simpson J, Gordon A, Maloney AF, Allison Y, Ritchie IM, Urquhart A.
    Brain Res; 1983 Nov 28; 280(1):119-26. PubMed ID: 6228286
    [Abstract] [Full Text] [Related]

  • 20. Regional difference in the kinetics of choline acetyltransferase in brains of neurologically normal elderly people and those with Alzheimer-type dementia.
    Koshimura K, Nakamura S, Miwa S, Fujiwara M, Kameyama M.
    J Neurol Sci; 1988 Apr 28; 84(2-3):141-6. PubMed ID: 3379442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.